A Phase 2 Trial of JKN24011 in COPD

Summary

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of Subcutaneous JKN24011 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Timeline

Start

2024-08-01

Primary completion

2026-04

Completion

2026-05

Drugs

Indications